Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats-Reference-Cited by-同舟云学术

Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats

Published:2015-10-13 Issue:10 Volume:10 Page:e0140399
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kumar Prashant,Lakshmi Yeruva Samrajya,C. Bhaskar,Golla Kishore,Kondapi Anand K.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference55 articles.

1. Quadruple nucleoside therapy with zidovudine, lamivudine, abacavir and tenofovir in the treatment of HIV;M Sturmer;Antiviral therapy,2007

2. AZT: an old drug with new perspectives;G D'Andrea;Current clinical pharmacology,2008

3. Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy;ER Scruggs;Pharmacology,2008

4. 3'-azido-3'-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7);O Barbier;Drug metabolism and disposition: the biological fate of chemicals,2000

5. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine;KD Kieburtz;Journal of acquired immune deficiency syndromes,1992

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cinnamaldehyde /naringin co-loaded into lactoferrin/ casienate-coated zein nanoparticles as a gastric resistance oral carrier for mitigating doxorubicin-induced hepatotoxicity;Journal of Drug Delivery Science and Technology;2024-06

2. Nanomedicine for the Treatment of Viral Diseases: Smaller Solution to Bigger Problems;Pharmaceutics;2024-03-16

3. Pharmacokinetic Drug-Drug Interactions Involving Antiretroviral Agents: An Update;Current Drug Metabolism;2023-07

4. Synergistic action of lactoferrin in enhancing the safety and effectiveness of docetaxel treatment against prostate cancer;Cancer Chemotherapy and Pharmacology;2023-03-29

5. Lactoferrin as a Component of Pharmaceutical Preparations: An Experimental Focus;Pharmaceuticals;2023-01-31